Cita APA

Kverneland, A. H., Enevold, C., Donia, M., Bastholt, L., Svane, I. M., & Nielsen, C. H. (2018). Development of anti-drug antibodies is associated with shortened survival in patients with metastatic melanoma treated with ipilimumab. Oncoimmunology.

Chicago Style Citation

Kverneland, Anders H., Christian Enevold, Marco Donia, Lars Bastholt, Inge Marie Svane, i Claus H. Nielsen. "Development of Anti-drug Antibodies Is Associated With Shortened Survival in Patients With Metastatic Melanoma Treated With Ipilimumab." Oncoimmunology 2018.

Cita MLA

Kverneland, Anders H., et al. "Development of Anti-drug Antibodies Is Associated With Shortened Survival in Patients With Metastatic Melanoma Treated With Ipilimumab." Oncoimmunology 2018.